US Therapeutic Hypothermia Systems Market Size, Share & Trends Analysis Report By Application (Neurology, Cardiology, Neonatal Care, and Others), By Product (Cooling Devices, Cooling Catheters, and Cool Caps), and Forecast, 2023 - 2030

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 US Therapeutic Hypothermia Systems Market, by Application
1.4.2 US Therapeutic Hypothermia Systems Market, by Product
1.5 Methodology for the research

Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
2.2.3 Market Opportunities
2.2.4 Market Challenges
2.2.5 Market Trends

Chapter 3. Competition Analysis - Global
3.1 Market Share Analysis, 2022
3.2 Strategies Deployed in the Therapeutic Hypothermia Systems Market
3.3 Porter’s Five Forces Analysis

Chapter 4. US Therapeutic Hypothermia Systems Market
4.1 US Therapeutic Hypothermia Systems Market, by Application
4.2 US Therapeutic Hypothermia Systems Market, by Product

Chapter 5. Company Profiles – Global Leaders
5.1 Asahi Kasei Corporation
5.1.1 Company Overview
5.1.2 Financial Analysis
5.1.3 Segmental and Regional Analysis
5.1.4 Research & Development Expenses
5.1.5 Recent strategies and developments:
5.1.5.1 Partnerships, Collaborations, and Agreements:
5.1.5.2 Acquisition and Mergers:
5.1.6 SWOT Analysis
5.2 Becton, Dickinson, and Company
5.2.1 Company Overview
5.2.2 Financial Analysis
5.2.3 Segmental and Regional Analysis
5.2.4 Research & Development Expense
5.2.5 Recent strategies and developments:
5.2.5.1 Product Launches and Product Expansions:
5.2.5.2 Acquisition and Mergers:
5.2.6 SWOT Analysis
5.3 Gentherm Incorporated
5.3.1 Company Overview
5.3.2 Financial Analysis
5.3.3 Segmental and Regional Analysis
5.3.4 Research & Development Expenses
5.3.5 SWOT Analysis
5.4 Stryker Corporation
5.4.1 Company Overview
5.4.2 Financial Analysis
5.4.3 Segmental and Regional Analysis
5.4.4 Research & Development Expense
5.4.5 Recent strategies and developments:
5.4.5.1 Product Launches and Product Expansions:
5.4.5.2 Acquisition and Mergers:
5.4.6 SWOT Analysis
5.5 Belmont Medical Technologies (Audax Management Company, LLC.)
5.5.1 Company Overview
5.5.2 SWOT Analysis
5.6 EM-MED Sp. z o.o. Sp. K.
5.6.1 Company Overview
5.6.2 SWOT Analysis
5.7 International Biomedical Ltd.
5.7.1 Company Overview
5.7.2 SWOT Analysis
5.8 Phoenix Medical Systems Pvt. Ltd.
5.8.1 Company Overview
5.8.2 SWOT Analysis
5.9 Shenzhen Comen Medical Instruments Co., Ltd.
5.9.1 Company Overview
5.9.2 SWOT Analysis
5.10. Terumo Corporation
5.10.1 Company Overview
5.10.2 Financial Analysis
5.10.3 Segmental and Regional Analysis
5.10.4 Research & Development Expenses
5.10.5 Recent strategies and developments:
5.10.5.1 Product Launches and Product Expansions:
5.10.5.2 Acquisition and Mergers:
5.10.6 SWOT Analysis